Beyond waste: understanding urine's potential in precision medicine

Area of Science:

• Nephrology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Urine-derived stem cells (USCs) represent a readily accessible and autologous source of stem cells.
• USCs hold significant promise for various biomedical applications, including cell therapy and disease modeling.
• The potential of USCs for precision medicine, utilizing a patient's own cells, is a key area of interest.

Purpose of the Study:

• To review the isolation and characterization methods for urine-derived stem cells (USCs).
• To discuss the preclinical applications of USCs in cell therapy and drug toxicity testing.
• To explore the utility of USCs and USC-derived induced pluripotent stem cells (u-iPSCs) in biomarker discovery for renal diseases.

Main Methods:

• Literature review of preclinical studies and research on urine-derived stem cells (USCs).
• Analysis of isolation, characterization, and differentiation protocols for USCs.
• Examination of studies investigating USC applications in renal therapy, drug testing, and biomarker discovery.

Main Results:

• USCs can be successfully isolated and characterized for various research purposes.
• Preclinical studies demonstrate the potential of USCs in cell therapy and drug toxicity assessments.
• USCs show promise as biomarkers for the diagnosis and monitoring of renal diseases.

Conclusions:

• Urine-derived stem cells (USCs) are a versatile tool for advancing renal therapy, drug testing, and biomarker discovery.
• Further research is essential to overcome challenges and fully realize the therapeutic and diagnostic potential of USCs.
• The use of autologous USCs supports the development of personalized medicine approaches for kidney disorders.